Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3548 | 963 | 33.7 | 42% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
574 | 13610 | FETAL ALCOHOL SYNDROME//PRENATAL ALCOHOL EXPOSURE//FETAL ALCOHOL SPECTRUM DISORDERS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
22414 | 325 | METHYLAZOXYMETHANOL//MICRENCEPHALY//CEREBELLAR DYSPLASIA |
27000 | 198 | EXPERIMENTAL BRAIN TUMORS//EXPERIMENTAL GLIOMA MODEL//NEUROCARCINOGENESIS |
28060 | 175 | GLUTEIN//MNU N METHYL N NITROSOUREA//RUNNING ACTIVITY |
31555 | 121 | VISUAL READAPTATION//VISUAL READAPTATION TIME//KETYS METHOD |
33489 | 91 | EMBRYOL TERATOL//MATERNAL IMMUNE STIMULATION//INBORN ANOMALIES |
35078 | 53 | BENZOYLATED DEAE CELLULOSE CHROMATOGRAPHY//POLYADENOSINE DIPHOSPHATE RIBOSE//N NITROSO N ETHYLUREA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | METHYLAZOXYMETHANOL | Author keyword | 28 | 48% | 4% | 43 |
2 | MICRENCEPHALY | Author keyword | 12 | 53% | 2% | 16 |
3 | EMBRYOL TERATOL | Address | 7 | 38% | 2% | 15 |
4 | EXPERIMENTAL BRAIN TUMORS | Author keyword | 6 | 80% | 0% | 4 |
5 | MATERNAL IMMUNE STIMULATION | Author keyword | 6 | 100% | 0% | 4 |
6 | MICROENCEPHALY | Author keyword | 4 | 34% | 1% | 10 |
7 | INBORN ANOMALIES | Author keyword | 4 | 75% | 0% | 3 |
8 | CEREBELLAR DYSPLASIA | Author keyword | 4 | 44% | 1% | 7 |
9 | BENZOYLATED DEAE CELLULOSE CHROMATOGRAPHY | Author keyword | 3 | 100% | 0% | 3 |
10 | FETOMATERNAL IMMUNOREACTIVITY | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIFFERENT GESTATIONAL DAYS | 15 | 88% | 1% | 7 |
2 | NONSPECIFIC STIMULATION | 12 | 59% | 1% | 13 |
3 | FETAL TREATMENT | 10 | 63% | 1% | 10 |
4 | MICROENCEPHALIC RATS | 7 | 56% | 1% | 9 |
5 | MICROENCEPHALIC RAT BRAIN | 6 | 80% | 0% | 4 |
6 | ENU | 6 | 53% | 1% | 8 |
7 | METHYLAZOXYMETHANOL ACETATE | 5 | 20% | 2% | 23 |
8 | RESIDENTIAL MAZE | 4 | 75% | 0% | 3 |
9 | PRENATAL DISRUPTION | 3 | 57% | 0% | 4 |
10 | ETHYLNITROSOUREA ENU | 3 | 100% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol | 1997 | 80 | 105 | 32% |
Neuroanatomical and functional alterations resulting from early postnatal cerebellar insults in rodents | 1996 | 38 | 63 | 25% |
Maternal immune stimulation in mice decreases fetal malformations caused by teratogens | 2002 | 16 | 33 | 42% |
Diverse ability of maternal immune stimulation to reduce birth defects in mice exposed to teratogens: a review | 2012 | 1 | 50 | 46% |
Animal Models of Brain Maldevelopment Induced by Cycad Plant Genotoxins | 2013 | 2 | 59 | 24% |
CYTO-TOXIC LESIONS AND THE DEVELOPMENT OF TRANSMITTER SYSTEMS | 1982 | 70 | 4 | 75% |
Effects of prenatal methylazoxymethanol treatment on striatal dopaminergic systems in rat brain | 1998 | 5 | 28 | 50% |
HEPATIC BLOOD-FLOW MEASUREMENT WITH INERT-GAS CLEARANCE | 1986 | 28 | 12 | 50% |
Mechanisms of neurotoxicity induced in the developing brain of mice and rats by DNA-damaging chemicals | 2011 | 5 | 178 | 16% |
Neurodegeneration in schizophrenia | 2010 | 10 | 160 | 15% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EMBRYOL TERATOL | 7 | 38% | 1.6% | 15 |
2 | SEZ ISTOCHIM CITOMETRIA | 2 | 21% | 0.8% | 8 |
3 | GOTEMBA S | 1 | 24% | 0.5% | 5 |
4 | BIOL CELLULARE NEUROBIOL | 1 | 13% | 0.6% | 6 |
5 | UNIDAD INVEST NEUROCIENCIAS | 1 | 50% | 0.1% | 1 |
6 | VET MED A17 | 1 | 50% | 0.1% | 1 |
7 | BASIC SCI GRP | 1 | 25% | 0.2% | 2 |
8 | PHARMACOL TARGET | 1 | 25% | 0.2% | 2 |
9 | DI S TE BA | 0 | 20% | 0.2% | 2 |
10 | IZOPHRENIA PET | 0 | 20% | 0.2% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000016833 | EMBRYONIC STEM CELL TEST//2 BUTOXYETHANOL//GLYCOL ETHERS |
2 | 0.0000011957 | CEREBELLUM//PURKINJE CELL//CLIMBING FIBERS |
3 | 0.0000010291 | FETAL ALCOHOL SYNDROME//PRENATAL ALCOHOL EXPOSURE//FETAL ALCOHOL SPECTRUM DISORDERS |
4 | 0.0000009567 | REELIN//DAB1//VLDLR |
5 | 0.0000009473 | BMAA//ALS PDC//BETA N METHYLAMINO L ALANINE |
6 | 0.0000008474 | MANDELBROT SET//GENERALIZED M J SETS//SUPRAMEDULLARY NEURONS |
7 | 0.0000007695 | OLFACTORY BULBECTOMY//CHRONIC MILD STRESS//LEARNED HELPLESSNESS |
8 | 0.0000007620 | ORTHO PHENYLPHENOL//SEX DISCRIMINATION OF CANCER RISK//HEPATOCARCINOGENESIS |
9 | 0.0000007544 | NADPH DIAPHORASE//7 NITROINDAZOLE//NEURONAL NITRIC OXIDE SYNTHASE |
10 | 0.0000007493 | CU GNRH//GRP MED PHARMACOL TOXICOL//GRP GYNAECOL ONCOL |